Abstract

Infections by pathogenic marine bacteria are a major problem for both the shellfish and finfish aquaculture industries, causing severe disease and high mortality, which seriously affect aquaculture production and cause significant economic loss. Marine pathogens like Vibrio tubiashii and Roseovarius crassostreae frequently cause disease in a variety of shellfish. With the understanding that the use of antibiotics in large-scale aquaculture leads to the development and transfer of antibiotic resistance, investigation of probiotic approaches for the prevention of infectious disease has become important. In manuscript I, screening of bacterial isolates from Rhode Island marine organisms and environment using agar-based assay methods for detection of antimicrobial activity against oyster pathogens led to the isolation of candidate probiotic bacteria Phaeobacter gallaeciensis S4. P. gallaeciensis S4 is a gram-negative a-Proteobacteria within the Roseobacter clade. Pretreatment of larval and juvenile oysters for 24 h with 104 CFU / mL of P. gallaeciensis S4 protected larval oysters against mortality resulting from challenge with R. crassostreae and V. tubiashii. Probiotic isolates had no negative impact on oyster survival. These results suggest the potential of marine bacterial isolate P. gallaeciensis S4 to serve as probiotic bacterium to control the infection and disease by bacterial pathogens in the culture of Crassostrea virginica. The probiotic bacterium P. gallaeciensis S4, isolated from the inner shell surface of a healthy oyster, secretes the antibiotic tropodithietic acid (TDA), is an excellent biofilm former, and increases oyster larvae survival when challenged with bacterialpathogens. In manuscript II, we investigated the specific roles of TDA secretion and biofilm formation in the probiotic activity of S4Sm (a spontaneous streptomycin-resistant mutant of the parental S4). For this purpose, mutations in clpX (ATP-dependent ATPase) and exoP (an exopolysaccharide biosynthesis gene) were created by insertional mutagenesis using homologous recombination. Mutation of clpX resulted in the loss of TDA production, no decline in biofilm formation, and loss of the ability of S4Sm to inhibit the growth of Vibrio tubiashii and Vibrio anguillarum in vitro. Mutation of exoP resulted in a ~70% decline in biofilm formation, no decline in TDA production, and delayed inhibitory activity towards Vibrio pathogens in vitro. Both clpX and exoP mutants exhibited reduced ability to protect oyster larvae from death when challenged by Vibrio tubiashii. Complementation of the clpX and exoP mutations restored the wild type phenotypes. We also found that pre-colonization by S4Sm was critical for this bacterium to inhibit pathogen colonization and growth. Our observations suggest

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.